Serum Levels of Advanced Glycation End Products Are Associated with In-Stent Restenosis in Diabetic Patients
Open Access
- 1 January 2005
- journal article
- Published by XMLink in Yonsei Medical Journal
- Vol. 46 (1) , 78-85
- https://doi.org/10.3349/ymj.2005.46.1.78
Abstract
Choi EY, et al. Yonsei Med J. 2005 Feb;46(1):78-85. http://dx.doi.org/10.3349/ymj.2005.46.1.78Keywords
This publication has 18 references indexed in Scilit:
- Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic PatientsCirculation, 2004
- Glycation, Inflammation, and RAGECirculation Research, 2003
- Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes MellitusNew England Journal of Medicine, 2003
- Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial InjuryCirculation, 2003
- Restenosis Rates in Diabetic PatientsCirculation, 1997
- Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.Circulation, 1990
- Glycation induces expansion of the molecular packing of collagenJournal of Molecular Biology, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979